Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.

Kloosterboer M, Hoffman G, Rock M, Gershan W, Laxova A, Li Z, Farrell PM.

Pediatrics. 2009 Feb;123(2):e338-46. doi: 10.1542/peds.2008-1681.

PMID:
19171585
2.
3.

Newborn screening programmes for cystic fibrosis.

Southern KW, Littlewood JM.

Paediatr Respir Rev. 2003 Dec;4(4):299-305. Review.

PMID:
14629952
4.

Newborn screening for cystic fibrosis.

Rock MJ.

Clin Chest Med. 2007 Jun;28(2):297-305. Review.

PMID:
17467549
5.

Newborn screening methods for cystic fibrosis.

Wilcken B, Wiley V.

Paediatr Respir Rev. 2003 Dec;4(4):272-7. Review.

PMID:
14629948
6.

[Newborn screening for cystic fibrosis, a clinical geneticist perspective].

Sanak M.

Przegl Lek. 2011;68(1):14-6. Review. Polish.

PMID:
21563437
7.

State-of-the-art for DNA technology in newborn screening.

McCabe ER, McCabe LL.

Acta Paediatr Suppl. 1999 Dec;88(432):58-60. Review.

PMID:
10626581
8.

Cystic fibrosis--its biochemical detection.

Heeley AF, Watson D.

Clin Chem. 1983 Dec;29(12):2011-8. Review.

9.

Newborn screening for cystic fibrosis.

Wagener JS, Zemanick ET, Sontag MK.

Curr Opin Pediatr. 2012 Jun;24(3):329-35. doi: 10.1097/MOP.0b013e328353489a. Review.

PMID:
22491493
10.

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS; CDC.

MMWR Recomm Rep. 2004 Oct 15;53(RR-13):1-36. Review.

11.

False negative newborn screen and neonatal cholestasis in a premature child with cystic fibrosis.

Heidendael JF, Tabbers MM, De Vreede I.

Eur J Pediatr. 2014 Dec;173(12):1581-3. doi: 10.1007/s00431-013-2135-z. Epub 2013 Aug 15. Review.

PMID:
23949094
12.

Neonatal screening for cystic fibrosis: present and future.

Wilcken B, Travert G.

Acta Paediatr Suppl. 1999 Dec;88(432):33-5. Review.

PMID:
10626574
13.

Newborn screening for cystic fibrosis.

Castellani C, Massie J, Sontag M, Southern KW.

Lancet Respir Med. 2016 Aug;4(8):653-661. doi: 10.1016/S2213-2600(16)00053-9. Epub 2016 Apr 1. Review.

PMID:
27053341
14.

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW; European Cystic Fibrosis Society Neonatal Screening Working Group.

J Cyst Fibros. 2009 Jan;8(1):71-8. doi: 10.1016/j.jcf.2008.09.005. Epub 2008 Oct 28.

15.

Cystic fibrosis screening in newborns: results from existing programs.

Young SS, Kharrazi M, Pearl M, Cunningham G.

Curr Opin Pulm Med. 2001 Nov;7(6):427-33. Review.

PMID:
11706321
16.

Newborn screening for cystic fibrosis: do we need a second IRT?

Price JF.

Arch Dis Child. 2006 Mar;91(3):209-10. Review. No abstract available.

17.

Newborn screening for cystic fibrosis.

Wagener JS, Sontag MK, Accurso FJ.

Curr Opin Pediatr. 2003 Jun;15(3):309-15. Review.

PMID:
12806263
18.

Neonatal screening: ethical aspects.

Hermerén G.

Acta Paediatr Suppl. 1999 Dec;88(432):99-103. Review.

PMID:
10626591
20.

Challenges in implementing a successful newborn cystic fibrosis screening program.

Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB.

J Pediatr. 2005 Sep;147(3 Suppl):S89-93. Review.

PMID:
16202791

Supplemental Content

Support Center